Polynovo Ltd Asset Resilience Ratio
Polynovo Ltd asset resilience ratio. Polynovo Ltd (PNV) has an Asset Resilience Ratio of 0.04% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Polynovo Ltd liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Polynovo Ltd (2000–2025)
Asset resilience ratio of Polynovo Ltd from 2000 to 2025. This chart shows how Polynovo Ltd's Asset Resilience Ratio has changed over time. Read PNV liabilities breakdown for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Polynovo Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see PNV asset base.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$0.00 | 0% |
| Short-term Investments | AU$50.00K | 0.04% |
| Total Liquid Assets | AU$50.00K | 0.04% |
Asset Resilience Insights
- Limited Liquidity: Polynovo Ltd maintains only 0.04% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Polynovo Ltd Industry Peers by Asset Resilience Ratio
Compare Polynovo Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
HOB Biotech Group Corp Ltd
SHG:688656 |
Medical Devices | 2.62% |
|
L&C Bio Co. Ltd
KQ:290650 |
Medical Devices | 2.14% |
|
Applied BioCode
TW:6598 |
Medical Devices | 9.75% |
|
Oncosil Medical Ltd
AU:OSL |
Medical Devices | 0.00% |
|
Cleo Diagnostics Ltd
AU:COV |
Medical Devices | 94.64% |
|
Radiant Innovation
TWO:3373 |
Medical Devices | 0.82% |
|
Impedimed Ltd
AU:IPD |
Medical Devices | 46.15% |
|
Memphasys Ltd
AU:MEM |
Medical Devices | 0.00% |
Polynovo Ltd Asset Resilience Ratio by Year (2000–2025)
Polynovo Ltd asset resilience ratio by year from 2000 to 2025. The table below shows the annual Asset Resilience Ratio data for Polynovo Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-06-30 | 5.46% | AU$6.96 Million ≈ $4.92 Million |
AU$127.41 Million ≈ $90.15 Million |
-16.88pp |
| 2024-06-30 | 22.34% | AU$24.29 Million ≈ $17.19 Million |
AU$108.72 Million ≈ $76.93 Million |
+22.29pp |
| 2023-06-30 | 0.05% | AU$50.00K ≈ $35.38K |
AU$92.62 Million ≈ $65.54 Million |
-0.09pp |
| 2022-06-30 | 0.14% | AU$50.00K ≈ $35.38K |
AU$34.97 Million ≈ $24.74 Million |
+0.01pp |
| 2021-06-30 | 0.13% | AU$50.00K ≈ $35.38K |
AU$38.34 Million ≈ $27.13 Million |
0.00pp |
| 2020-06-30 | 0.13% | AU$50.00K ≈ $35.38K |
AU$37.86 Million ≈ $26.79 Million |
-0.05pp |
| 2019-06-30 | 0.18% | AU$50.00K ≈ $35.38K |
AU$28.23 Million ≈ $19.97 Million |
-63.70pp |
| 2018-06-30 | 63.88% | AU$19.05 Million ≈ $13.48 Million |
AU$29.82 Million ≈ $21.10 Million |
+63.46pp |
| 2017-06-30 | 0.41% | AU$50.00K ≈ $35.38K |
AU$12.06 Million ≈ $8.53 Million |
+0.10pp |
| 2016-06-30 | 0.31% | AU$50.00K ≈ $35.38K |
AU$16.02 Million ≈ $11.34 Million |
-0.43pp |
| 2015-06-30 | 0.74% | AU$60.00K ≈ $42.45K |
AU$8.13 Million ≈ $5.75 Million |
+0.10pp |
| 2014-06-30 | 0.64% | AU$60.00K ≈ $42.45K |
AU$9.41 Million ≈ $6.66 Million |
-12.82pp |
| 2013-06-30 | 13.46% | AU$1.16 Million ≈ $820.77K |
AU$8.62 Million ≈ $6.10 Million |
-7.42pp |
| 2012-06-30 | 20.88% | AU$1.86 Million ≈ $1.32 Million |
AU$8.91 Million ≈ $6.30 Million |
-11.06pp |
| 2011-06-30 | 31.94% | AU$3.76 Million ≈ $2.66 Million |
AU$11.77 Million ≈ $8.33 Million |
+31.54pp |
| 2010-06-30 | 0.40% | AU$60.00K ≈ $42.45K |
AU$15.02 Million ≈ $10.63 Million |
-86.21pp |
| 2000-06-30 | 86.61% | AU$10.36 Million ≈ $7.33 Million |
AU$11.96 Million ≈ $8.46 Million |
-- |
About Polynovo Ltd
PolyNovo Limited designs, manufactures, and sells biodegradable medical devices in Australia, New Zealand, the United States, the United Kingdom, Ireland, Singapore, India, and Hong Kong. The company offers NovoSorb Biodegradable Temporising Matrix, a dermal matrix for the regeneration of the dermis when lost through extensive surgery, trauma, or burn. It is also developing hernia devices for her… Read more